CFLAR and prostate carcinoma: c-FLIP is aberrantly expressed in both high grade prostate cancer and CRPC and is a direct target for AR-mediated transcriptional activity [9–11]; the c-FLIP gene promoter contains defined androgen response elements (AREs).